On the opposite spectrum, one of the best performers of the year is Actavis. This generic drug company has rallied 46 percent year to date and up 700 percent in almost ten years. Actavis has become a major competitor through gobbling up companies in smart acquisitions. Additionally, Actavis might even be willing to swoop in and rescue Allergan from Valeant's hostile takeover attempts.
To gain further insight, Cramer spoke with Actavis President and CEO, Brent Saunders on whether Actavis could acquire Allergan.
"We won't do any hostile bids that's not who we are. We are about value creation and if we go back to that theme, hostile deals don't create value. Particularly in a specialty pharmaceutical business where people matter," said Saunders.
To get a read on what is happening in the healthcare sector, especially the pharmaceutical industry, Cramer spoke with Fred Hassan, the managing director and managing partner at Warburg Pincus and chairman of Bausch & Lomb.
"This man has more expertise and managing acumen in his pinky than many CEOs have in their whole bodies. So pay attention," said Cramer.
Hassan gave his take on the future of the healthcare sector when he said, "This is going to be the life sciences century….This is because there are three things happening. Number one, there are new technologies in the genome area. You've also got information technology, and then there are academic centers creating a fantastic knowledge on biological systems. These three things are unleashing so much knowledge and there are so many advances going on in cancer and many other areas."
In the Lightning Round, Cramer gave his post-election take on a few caller favorite stocks:
Illumina: "If Illumina gets hit on a day when the market is down because of a broader issue that has nothing to do with life sciences, that's when you pull the trigger to buy. It's a great company, I actually like Thermo-Fisher too"
The GEO Group: "I'm not a big fan of the prison industry, it's contracted by contractors and I'm always afraid one of them is going to lose one and it is unpredictable to me."
Read MoreLightning Round: Time to pull the trigger on this one